Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.5.0.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Oct. 31, 2010
Oct. 31, 2009
Net revenue $ 11,509,933 $ 13,224,435
Cost of revenue 6,175,633 6,315,961
Gross profit 5,334,300 6,908,474
Operating Expenses:    
Research and development 1,762,035 2,652,713
Selling, general and administrative expenses 6,382,598 10,996,833
Total operating expenses 8,144,633 13,649,546
Operating loss (2,810,333) (6,741,072)
Other Income (Expense):    
Other income, net 1,750,477 201,748
Amortization of deferred financing costs (1,270,170) (242,128)
Interest expense (2,005,836) (1,846,883)
Change in the fair value of warrant liability 2,557,546
Impairment of investment in marketable securities (782,595)
Total other income (expense) 1,032,017 (2,669,858)
Loss before income taxes (1,778,316) (9,410,930)
Provision for income taxes (22,208)
Net loss (1,778,316) (9,433,139)
Net Loss Applicable to Common Shares $ (1,778,316) $ (9,480,520)
Loss per share, basic and diluted $ (0.04) $ (0.19)
Weighted average shares outstanding 49,247,694 48,707,615
Comprehensive loss:    
Net loss $ (1,778,316) $ (9,433,139)
Foreign currency translation adjustment (282,725) (143,921)
Unrealized loss on available for sale investment (17,000)
Comprehensive loss (2,061,041) (9,594,059)
Series A Preferred Stock [Member]    
Other Income (Expense):    
Preferred Stock Dividends (47,382)
Series B Preferred Stock [Member]    
Other Income (Expense):    
Preferred Stock Dividends